Comments

Pharming Stock Price, Quotes and Forecasts

Q: What sector and industry does Pharming (PHAR) operate in?

Pharming is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

PHARNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$9.00

At close: May 7 EDT

$8.63

-0.37-4.11%

Pre-Market: 9:16 AM EDT

Q1 2025 earnings were released today before the market open

Today's conference call ended over 5 hours ago Click to view the webcast

Pharming (PHAR) Forecast

News Earnings Pharming (PHAR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Pharming Stock Price, Quotes and Forecasts | NASDAQ:PHAR | Benzinga

Explore Pharming stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PHAR.

Open	-
Close	-
Volume / Avg.	36.00 / 6.23K
Day Range	- - -
52 Wk Range	6.65 - 11.07
Market Cap	$590.23M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	-
Days to Cover	1

Recent News

G-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems, Dollar General And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug

Pharming's Phase 3 trial results for leniolisib in children with APDS demonstrate efficacy and safety, supporting future regulatory filings in 2025.

Vandana Singh

Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	36.00 / 6.23K
Day Range	- - -
52 Wk Range	6.65 - 11.07
Market Cap	$590.23M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	-
Days to Cover	1

About Pharming Group N.V.

Sector

Health Care

Industry

Biotechnology

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rar...

Got Questions? Ask

How is PHAR's EV/EBITDA ratio?

How is PHAR's price-to-book ratio?

What does PHAR's DCF valuation show?

What is PHAR's current market cap?

What is PHAR's gross margin?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Pharming (PHAR) stock?

You can purchase shares of Pharming (NASDAQ:PHAR) through any online brokerage.

View our list of the best stock brokerages

Who are Pharming (PHAR) competitors?

Other companies in Pharming’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT) and Replimune Group (NASDAQ:REPL).

What is the forecast, or price target, for Pharming (PHAR) stock?

Pharming has a consensus price target of $30.00.

What is the current price for Pharming (PHAR)?

The stock price for Pharming (NASDAQ: PHAR) is $8.63 last updated May 7, 2025 at 9:16 AM EDT.

Does Pharming (PHAR) pay a dividend?

There are no upcoming dividends for Pharming.

When is Pharming (NASDAQ:PHAR) reporting earnings?

Pharming’s Q2 earnings are confirmed for Thursday, July 31, 2025.

Is Pharming (PHAR) going to split?

There is no upcoming split for Pharming.

What sector and industry does Pharming (PHAR) operate in?

Pharming is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.